Answer
Headache was reported in 12% of children and 12% of adults receiving somapacitan for growth hormone deficiency.
Sources for this answer
- Sogroya 10mg/1.5 mL solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked